Naringin inhibits P2X4 receptor expression on satellite glial cells in the neonatal rat dorsal root ganglion

J Appl Biomed. 2023 Dec;21(4):193-199. doi: 10.32725/jab.2023.021. Epub 2023 Dec 4.

Abstract

Naringin inhibits inflammation and oxidative stress, the P2 purinoreceptor X4 receptor (P2X4R) is associated with glial cell activation and inflammation, the purpose of this study is to investigate the effects of naringin on P2X4 receptor expression on satellite glial cells (SGCs) and its possible mechanisms. ATP promoted the SGC activation and upregulated P2X4R expression; naringin inhibited SGC activation, decreased expression of P2X4R, P38 MAPK/ERK, and NF-κB, and reduced levels of Ca2+, TNF-α, and IL-1β in SGCs in an ATP-containing environment. These findings suggest that naringin attenuates the ATP-induced SGC activation and reduces P2X4R expression via the Ca2+-P38 MAPK/ERK-NF-κB pathway.

Keywords: Glial cell activation; Inflammation; Naringin; P2X4R; Satellite glial cells.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Animals, Newborn
  • Calcium / metabolism
  • Calcium / pharmacology
  • Ganglia, Spinal / metabolism
  • Inflammation
  • NF-kappa B* / metabolism
  • Neuroglia / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X4* / genetics
  • Receptors, Purinergic P2X4* / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism
  • p38 Mitogen-Activated Protein Kinases / pharmacology

Substances

  • Receptors, Purinergic P2X4
  • naringin
  • NF-kappa B
  • Calcium
  • p38 Mitogen-Activated Protein Kinases
  • Adenosine Triphosphate